VJRegenMed is committed to improving our service to you

Share this video  

VJRegenMed is committed to improving our service to you

Advanced Therapies Week 2022 | The benefits of universal immune receptors in cell therapy

Jeff Liter, MBA, Luminary Therapeutics, Minneapolis, MN, describes the advantages of universal immune receptors and how they can address issues relating to chimeric antigen receptor (CAR) T-cell therapies. Patients receiving CAR T-cell therapies can experience antigen escape and T-cell exhaustion and universal immune receptors can overcome these issues by having the ability to be turned on or off. This property enables the antigen to be changed in the event of antigen escape and rest the T cells if T-cell exhaustion occurs. This interview took place at Advanced Therapies Week 2022.

Disclosures

Jeff Liter is an employee of Luminary Therapeutics.